Es gab 50 kürzliche Insider-Transaktionen für Cellectar Biosciences, Inc. (CLRB), darunter 46 Käufe und 3 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $8.96M und die gesamten Insider-Verkäufe auf $731.99.
Bedeutende Insider mit kürzlicher Aktivität umfassen Neis John, Caruso James V, Longcor Jarrod. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — CLRB
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-12-12 |
Neis John |
Director |
Informierter Verkauf |
198 |
$3.70 |
$731.99 |
10 |
| 2025-07-02 |
Caruso James V |
Chief Executive Officer |
Informierter Kauf |
10,000 |
$5.25 |
$52.5K |
10,000 |
| 2025-07-02 |
Longcor Jarrod |
Chief Operating Officer |
Informierter Kauf |
10,000 |
$5.25 |
$52.5K |
10,000 |
| 2025-07-02 |
Kolean Chad J |
Chief Financial Officer |
Informierter Kauf |
5,000 |
$5.25 |
$26.25K |
5,000 |
| 2025-02-14 |
Driscoll Frederick W |
Director |
RSU-Zuteilung |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Neis John |
Director |
RSU-Zuteilung |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Caruso James V |
President and CEO |
RSU-Zuteilung |
900,000 |
$0.29 |
$261K |
900,000 |
| 2025-02-14 |
Swirsky Douglas J |
Director |
RSU-Zuteilung |
90,000 |
$0.29 |
$26.1K |
90,000 |
| 2025-02-14 |
Loren Stefan |
Director |
RSU-Zuteilung |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Longcor Jarrod |
Chief Operating Officer |
RSU-Zuteilung |
500,000 |
$0.29 |
$145K |
500,000 |
| 2025-02-14 |
Kolean Chad J |
Chief Financial Officer |
RSU-Zuteilung |
290,000 |
$0.29 |
$84.1K |
290,000 |
| 2025-02-14 |
Chanan-khan Asher |
Director |
RSU-Zuteilung |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-01-10 |
Longcor Jarrod |
Chief Operating Officer |
Informierter Kauf |
30,000 |
$0.28 |
$8.4K |
83,141 |
| 2024-06-14 |
Driscoll Frederick W |
Director |
RSU-Zuteilung |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Neis John |
Director |
RSU-Zuteilung |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Caruso James V |
President and CEO |
RSU-Zuteilung |
900,000 |
$2.65 |
$2.39M |
900,000 |
| 2024-06-14 |
Swirsky Douglas J |
Director |
RSU-Zuteilung |
90,000 |
$2.58 |
$232.2K |
90,000 |
| 2024-06-14 |
Loren Stefan |
Director |
RSU-Zuteilung |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Longcor Jarrod |
Chief Operating Officer |
RSU-Zuteilung |
500,000 |
$2.65 |
$1.33M |
500,000 |
| 2024-06-14 |
Kolean Chad J |
Chief Financial Officer |
RSU-Zuteilung |
290,000 |
$2.65 |
$768.5K |
290,000 |
| 2024-06-14 |
Chanan-khan Asher |
Director |
RSU-Zuteilung |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Lea Darrell Shane |
Chief Commercial Officer |
RSU-Zuteilung |
260,000 |
$2.65 |
$689K |
260,000 |
| 2024-06-14 |
Shustov Andrei |
Senior Vice President, Medical |
RSU-Zuteilung |
260,000 |
$2.65 |
$689K |
260,000 |
| 2023-12-08 |
Caruso James V |
President and CEO |
RSU-Zuteilung |
40,596 |
- |
- |
49,236 |
| 2023-12-08 |
Longcor Jarrod |
Chief Operating Officer |
RSU-Zuteilung |
42,927 |
- |
- |
53,141 |
| 2023-12-08 |
Kolean Chad J |
Chief Financial Officer |
RSU-Zuteilung |
42,554 |
- |
- |
42,578 |
| 2023-12-08 |
Lea Darrell Shane |
Chief Commercial Officer |
RSU-Zuteilung |
39,599 |
- |
- |
39,599 |
| 2023-12-08 |
Shustov Andrei |
Senior Vice President, Medical |
RSU-Zuteilung |
47,856 |
- |
- |
55,038 |
| 2023-06-28 |
Driscoll Frederick W |
Director |
RSU-Zuteilung |
25,000 |
$1.85 |
$46.25K |
47,650 |
| 2023-06-28 |
Neis John |
Director |
RSU-Zuteilung |
25,000 |
$1.85 |
$46.25K |
47,887 |
| 2023-06-28 |
Swirsky Douglas J |
Director |
RSU-Zuteilung |
37,500 |
$1.85 |
$69.38K |
71,925 |
| 2023-06-28 |
Loren Stefan |
Director |
RSU-Zuteilung |
25,000 |
$1.85 |
$46.25K |
47,885 |
| 2023-06-28 |
Chanan-khan Asher |
Director |
RSU-Zuteilung |
25,000 |
$1.85 |
$46.25K |
40,600 |
| 2023-06-23 |
Caruso James V |
President and CEO |
RSU-Zuteilung |
261,000 |
$1.68 |
$438.48K |
261,000 |
| 2023-06-23 |
Longcor Jarrod |
Chief Operating Officer |
RSU-Zuteilung |
144,000 |
$1.68 |
$241.92K |
144,000 |
| 2023-06-23 |
Kolean Chad J |
Chief Financial Officer |
RSU-Zuteilung |
104,000 |
$1.68 |
$174.72K |
104,000 |
| 2023-06-23 |
Lea Darrell Shane |
Chief Commercial Officer |
RSU-Zuteilung |
100,000 |
$1.68 |
$168K |
100,000 |
| 2023-02-15 |
Shustov Andrei |
Senior Vice President, Medical |
Veräußerung |
- |
- |
- |
7,182 |
| 2023-02-15 |
Shustov Andrei |
Senior Vice President, Medical |
RSU-Zuteilung |
100,000 |
$1.67 |
$167K |
100,000 |
| 2023-01-17 |
Caruso James V |
President and CEO |
RSU-Zuteilung |
261,000 |
- |
- |
261,000 |
| 2023-01-17 |
Longcor Jarrod |
Chief Operating Officer |
RSU-Zuteilung |
144,000 |
- |
- |
144,000 |
| 2023-01-17 |
Kolean Chad J |
Chief Financial Officer |
RSU-Zuteilung |
104,000 |
- |
- |
104,000 |
| 2022-11-21 |
Lea Darrell Shane |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2022-11-21 |
Lea Darrell Shane |
Chief Commercial Officer |
RSU-Zuteilung |
100,000 |
- |
- |
100,000 |
| 2022-06-24 |
Driscoll Frederick W |
Director |
RSU-Zuteilung |
7,800 |
- |
- |
7,800 |
| 2022-06-24 |
Neis John |
Director |
RSU-Zuteilung |
7,800 |
- |
- |
7,800 |
| 2022-06-24 |
Swirsky Douglas J |
Director |
RSU-Zuteilung |
11,700 |
$4.10 |
$47.97K |
11,700 |
| 2022-06-24 |
Loren Stefan |
Director |
RSU-Zuteilung |
7,800 |
$4.10 |
$31.98K |
7,800 |
| 2022-06-24 |
Chanan-khan Asher |
Director |
RSU-Zuteilung |
7,800 |
- |
- |
7,800 |
| 2022-02-24 |
Kolean Chad J |
Chief Financial Officer |
Veräußerung |
- |
- |
- |
240 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
